Member Info for mbingo

Any sign of Institutional buying and the trend will clearly reverse. Cap at £127m. This stock has been beaten down. 90p mid-February. It's not an airline or an oil company. It doesn't have unmanageable debt levels. UK Government committed to infrastructure/construction spend. Cost is being managed by Board. Cash positioned actually increased over last month to £142m.

https://www.sigplc.com/investors/results-centre

Worth reviewing 2019 half year presentation to see focus on margin improvement.

Company market cap at £132m a nonsense with cash at these levels and more than £2Bn revenue. sector on the Up given infrastructure spend and focus on improving margins per operational announcements in 2019.

Cash at £142m. No change to underlying profit before tax of £42m. Excellent Cost control. Business re-opened in France, much re-opened in Uk and Germany. Excellent news!!

https://www.constructionenquirer.com/2020/04/29/major-contractors-now-working-on-70-of-sites/

I expect that JP Morgan is still selling the stock that they have to the market, hence prices. We know that three other institutions have been stake building since Covid 19 and the new CEO appointment - IKO, Goldman Sachs, Aberforth. We also know that the company's cash position more than covers its debt (v important in this climate) and that the company have been implementing cost saving measures across the business. We also know that the company are re-opening part of the business and that construction work is being prioritised across UK (Infrastructure spend in budget) and Spain/Germany. Very interested to hear the go-forward strategy and positioned here and in another for what i believe will be an upturn in the sector.

My largest position right now. Limited downside at these prices as the business re-opens.

Yes, company website - investor relations up to date besides latest JP Morgan sale. Goldman’s have approx 6%, bought Feb/March this year (so recent purchase). Aberforth new also with 6% ish. IKO Enterprises increased to 14.7% from 6% in January. Look forward to the company results and go forward strategy, expected next week. Re-opening of outlets clearly a result of increased demand.

IKO increased their interest from 6.85% on December 31st to 14.77% 20 April. Goldman Sachs are new (5.76%) and Aberforth Partners (6.55%) also new (since new CEO). This has fallen so far and has very limited debt. Backed by £135m cash. I’m backing the recovery. Old board clearly paid themselves a fat cheque! I like the way that this board have taken a 50% cut whilst operations disrupted - shows alignment.

Yes, per RNS

Probably one of the nine other institutional investors is picking up the slack!

This is huge reason to invest in the sector and SIG plc plus of course the construction companies well set. The 2020 budget in the UK was all about Covid and infrastructure/construction/housing - big focus.

Yep, agree. Massive volume yesterday.

seems to be in the 18-21 range currently, needs to break clear of 21 for the next leg. Bought more in the 18s. Personally I'm very confident in the recovery here over next couple of months. We'll see.

They were buying 10.5% until April12/13 and have sold down to 9.5% - can't believe that they would plan to buy 10% and sell it all back again in the same month, just playing with their position a bit.

JP Morgan not the only new institutional investor since the new CEO/CFO. Goldman Sachs (5.76%), Aberforth (6.55%) are New. IKO enterprises up to 14.77% from about 7% in January.

A clear buy at these levels from a Fundamental perspective and technicals now matching with the bounce off 15ish. Is £500m market cap a reasonable valuation? That’s about 85/90p.

Personally added a lot at 17.5 ish today.

Closely held stock 75/76% in tight hands - from company share registrar. Once Lombard are through with selling their 1.65% stake from March 23 (if they want to sell it all), this should move fast.

Lombard were down to 1.65% at 23 March, Monday will be 4 weeks on from that. Valuation seems wrong at GBP25m given that they are working “day and night” as part of the Ventilator consortium and have received orders of more than £5m so far for the NHS. Should be a pivotal year for the business. It was the US business that made positive revenue growth last year. UK domestic business clearly thriving now. Financials were reported April 30 last year so we should hear something soon if we don’t hear anything else in the meantime around ventilator orders.